Insight Molecular (IMDX): Net earnings per share (EPS TTM)

Corporate company logo of Insight Molecular Diagnostics (IMDX)

Insight Molecular Diagnostics relies on stable, non-cyclical demand within the healthcare sector. Outsourcing production and IT solutions optimizes the turnaround time for results. The company's net income per share over the last 12 months demonstrates business resilience, while -1.49 indicates the current level. The final outcome depends on the demand for test systems and the successful certification of new pathogen panels.

IMDX Insight Molecular Net earnings per share for the last four quarters (06/19/2025 - 11/12/2026)

Financial and market metric breakdowns for Insight Molecular Diagnostics, Inc. (IMDX)

- current quotes and average value forecast:
Price Chart Insight Molecular|IMDX - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Insight Molecular Diagnostics Inc|IMDX - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Insight Molecular Diagnostics|IMDX - Book Valuation of Business|Market Capitalization to Book Value Ratio imdxinc.com|IMDX - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Debt to Equity Insight Molecular Diagnostics|IMDX - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Insight Molecular|IMDX - Company Total Debt Obligations|Debts to Book Capitalization Insight Molecular Diagnostics Inc|IMDX - Long-Term Debt Volume|Company Short-Term Debts Insight Molecular Diagnostics|Quick Ratio imdxinc.com
- earnings and multiples data:
IMDX - Final Profit|Future Profit Insight Molecular Diagnostics|IMDX - Market Price to Net Income Ratio|Projected Price to Earnings Insight Molecular|IMDX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Insight Molecular Diagnostics Inc|IMDX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Insight Molecular Diagnostics|IMDX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months imdxinc.com|IMDX - Earnings per share growth in current year|Earnings growth forecast for next year Insight Molecular Diagnostics
Fundamental company analysis:imdxinc.com (IMDX)
Mass-produced product of Insight Molecular

Earnings per share (EPS TTM) measures the portion of profit allocated to each security over the last four quarters. Investors utilize this ratio to determine the intrinsic value of a business and forecast capital growth rates. By analyzing the trend of the rolling 12-month earnings per share, one can identify if an asset is overbought. For Insight Molecular Diagnostics (IMDX), this indicator reflects the resilience of molecular diagnostics. Stable demand for testing protects the company's profitability from economic cycles.

Competitors of Insight Molecular Diagnostics

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NNNN|Net earnings per share for the last four quarters soterahealth.com|Earnings per share for the last twelve months QuidelOrtho Corporation QDEL|OPK: Earnings per share for the last 12 months|CDNA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Maravai MRVI|FLGT: Net earnings per share (EPS TTM)|LAB - Net earnings per share for the last four quarters|CTKB (Cytek Biosciences) - Net earnings per share (EPS TTM)|OSUR - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) XGN|MDXH (MDxHealth, Inc.) - Earnings per share for the trailing year|Lucid Diagnostics Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters PRE (Prenetics Global Limited)|TRIB: Net earnings per share for the last 12 months|Earnings per share for the trailing year PRPH (ProPhase Labs Inc)|Ainos Corp (AIMD) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months CoDx|Earnings per share for the last twelve months Heart Test Laboratories|Net earnings per one share for the last twelve months biomerica.com BMRA|Earnings per share for the last twelve months Cardio Diagnostics (CDIO)|Earnings per share for the last twelve months ONCO (Onconetix Inc)|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group Ltd)|Bluejay Diagnostics Corp (BJDX) - Net earnings per one share for the last twelve months|Aspira Women's Health - Net earnings per share (EPS TTM)|acceleratediagnostics.com (AXDX) - Net earnings per share for the last 12 months|CNTG (Centogene N.V.) - Net earnings per share for the last 12 months|Enzo Biochem (ENZ) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fresh2 Group Ltd|Earnings per share for the last twelve months GENE|Net earnings per share (EPS TTM) ME|Net earnings per share (EPS TTM) psychemedics.com (PMD)